Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Long-Term Deferred Tax: 2024-2025

Historic Long-Term Deferred Tax for Puma Biotechnology (PBYI) over the last 1 years, with Sep 2025 value amounting to $7.1 million.

  • Puma Biotechnology's Long-Term Deferred Tax was N/A to $7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 million, marking a year-over-year change of. This contributed to the annual value of $7.1 million for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Puma Biotechnology's Long-Term Deferred Tax is $7.1 million, which was down 0.00% from $7.1 million recorded in Q2 2025.
  • In the past 5 years, Puma Biotechnology's Long-Term Deferred Tax ranged from a high of $7.1 million in Q4 2024 and a low of $7.1 million during Q4 2024.
  • Its 2-year average for Long-Term Deferred Tax is $7.1 million, with a median of $7.1 million in 2025.